The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
CpG DNA as a vaccine adjuvant
Open accessAbstract
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs trigger cells that express Toll-like receptor 9 (including human plasmacytoid dendritic cells and B cells) to mount an innate immune response characterized by the production of Th1 and proinflammatory cytokines. When used as vaccine adjuvants, CpG ODNs improve the function of professional antigen-presenting cells and boost the generation of humoral and cellular vaccine-specific immune responses. These effects are optimized by maintaining ODNs and vaccine in close proximity. The adjuvant properties of CpG ODNs are observed when administered either systemically or mucosally, and persist in immunocompromised hosts. Preclinical studies indicate that CpG ODNs improve the activity of vaccines targeting infectious diseases and cancer. Clinical trials demonstrate that CpG ODNs have a good safety profile and increase the immunogenicity of coadministered vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 6×
“Only transfection with TLR-9 conferred responsiveness to CpG ODNs or bacterial DNA [9,10].”
BackgroundInfluentialDirect Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationRecognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605
Contribution of CpG motifs to the immunogenicity of DNA vaccines
Klinman, D. M., Yamshchikov, G., & Ishigatsubo, Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3635 · Cited by 507
Self-citation
Research works printed but not linked: 136
- 10.1016/j.cell.2006.02.015 · DOI · Paper page
- 10.1128/CMR.00046-08 · DOI · Paper page
- 10.1038/ni.1863 · DOI · Paper page
- Paul WE. Fundamental Immunology . Raven Press, New York, NY, USA (1993).
- Razin, 1981, Prog. Nucleic Acid Res. Mol. Biol., 25, 33, 10.1016/S0079-6603(08)60482-1 · DOI
- Cardon, 1994, Proc. Natl Acad. Sci. USA, 91, 3799, 10.1073/pnas.91.9.3799 · DOI · Paper page
- 10.4049/jimmunol.167.7.3555 · DOI · Paper page
- 10.1073/pnas.161293498 · DOI · Paper page
- 10.1016/S0065-2776(08)60790-7 · DOI · Paper page
- 10.1038/386336a0 · DOI · Paper page
- Sparwasser, 1997, Eur. J. Immunol., 27, 1671, 10.1002/eji.1830270712 · DOI · Paper page
- Ishii, 2002, J. Exp. Med., 196, 269, 10.1084/jem.20020773 · DOI
- Gursel, 2002, J. Leukoc. Biol., 71, 813, 10.1189/jlb.71.5.813 · DOI
- 10.4049/jimmunol.168.9.4531 · DOI
- 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H · DOI
- 10.4049/jimmunol.166.8.5000 · DOI · Paper page
- 10.4049/jimmunol.166.4.2372 · DOI
- 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U · DOI
- 10.1002/eji.200323813 · DOI · Paper page
- 10.1189/jlb.1202630 · DOI · Paper page
- 10.1089/oli.2009.0210 · DOI
- 10.1016/j.jconrel.2004.02.022 · DOI
- Ballas, 1996, J. Immunol., 157, 1840, 10.4049/jimmunol.157.5.1840 · DOI · Paper page
- 10.1038/nature03547 · DOI · Paper page
- 10.1084/jem.20060401 · DOI · Paper page
- 10.1038/nrd2059 · DOI · Paper page
- 10.1016/j.addr.2008.12.008 · DOI · Paper page
- 10.1016/j.addr.2007.12.004 · DOI · Paper page
- 10.1189/jlb.1008671 · DOI
- Klaschik, 2010, Mol. Immunol., 47, 1317, 10.1016/j.molimm.2009.11.014 · DOI
- 10.1073/pnas.93.7.2879 · DOI · Paper page
- Sun, 1998, J. Exp. Med., 188, 2335, 10.1084/jem.188.12.2335 · DOI
- Stacey, 1996, J. Immunol., 157, 2116, 10.4049/jimmunol.157.5.2116 · DOI · Paper page
- 10.1038/nm0897-849 · DOI · Paper page
- 10.1016/j.bbrc.2004.06.059 · DOI
- Yi, 1996, J. Immunol., 157, 5394, 10.4049/jimmunol.157.12.5394 · DOI · Paper page
- Davis, 1998, J. Immunol., 160, 870, 10.4049/jimmunol.160.2.870 · DOI · Paper page
- Kobayashi, 1999, Cell. Immunol., 198, 69, 10.1006/cimm.1999.1572 · DOI
- 10.4049/jimmunol.169.5.2368 · DOI
- 10.1002/eji.200535744 · DOI · Paper page
- 10.1016/j.immuni.2005.02.008 · DOI
- 10.1073/pnas.96.16.9305 · DOI · Paper page
- 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q · DOI · Paper page
- 10.4049/jimmunol.170.9.4465 · DOI · Paper page
- 10.1146/annurev.immunol.20.100301.064842 · DOI · Paper page
- Ishii, 2003, Eur. J. Immunol., 35, 2397, 10.1002/eji.200425795 · DOI
- 10.1111/j.1348-0421.1994.tb01867.x · DOI
- 10.1016/S0264-410X(98)00151-0 · DOI · Paper page
- 10.1002/eji.1830270931 · DOI · Paper page
- 10.1084/jem.186.10.1623 · DOI · Paper page
- 10.4049/jimmunol.167.6.3324 · DOI
- 10.1080/08830180600743057 · DOI
- Tross, 2008, J. Immunol., 181, 5785, 10.4049/jimmunol.181.8.5785 · DOI
- Crompton, 2008, J. Infect. Dis., 198, 1265, 10.1086/592224 · DOI
- Overstreet, 2010, Eur. J. Immunol., 40, 124, 10.1002/eji.200939493 · DOI
- Muraoka, 2010, J. Immunol., 185, 3768, 10.4049/jimmunol.0903649 · DOI
- 10.4049/jimmunol.168.12.6099 · DOI
- Sandler, 2003, Cancer Res., 63, 394
- 10.1084/jem.20052433 · DOI · Paper page
- McCluskie, 1998, J. Immunol., 161, 4463, 10.4049/jimmunol.161.9.4463 · DOI
- von Hunolstein, 2001, Vaccine, 19, 3058, 10.1016/S0264-410X(01)00048-2 · DOI
- Kovarik, 1999, J. Immunol., 162, 1611, 10.4049/jimmunol.162.3.1611 · DOI
- Eastcott, 2001, Vaccine, 19, 1636, 10.1016/S0264-410X(00)00422-9 · DOI
- Al Mariri, 2001, Infect. Immun., 69, 4816, 10.1128/IAI.69.8.4816-4822.2001 · DOI
- Xie, 2005, Infect. Immun., 73, 828, 10.1128/IAI.73.2.828-833.2005 · DOI
- Fogg, 2007, Vaccine, 25, 2787, 10.1016/j.vaccine.2006.12.037 · DOI
- 10.1128/IAI.71.9.5121-5129.2003 · DOI
- Klinman, 2007, Microbes Infect., 9, 1478, 10.1016/j.micinf.2007.08.002 · DOI
- 10.1128/JVI.02013-05 · DOI
- 10.4049/jimmunol.166.5.3451 · DOI
- Huang, 2008, J. Pediatr. Gastroenterol. Nutr., 46, 262, 10.1097/MPG.0b013e318156050d · DOI
- 10.1016/j.vaccine.2004.08.019 · DOI
- Rothenfusser, 2004, Blood, 103, 2162, 10.1182/blood-2003-04-1091 · DOI
- 10.1067/mai.2000.107927 · DOI · Paper page
- 10.1097/CJI.0b013e318183af0b · DOI
- Mukherjee, 2007, Vaccine, 25, 1607, 10.1016/j.vaccine.2006.11.007 · DOI
- Miller, 1989, J. Gerontol., 44, B4, 10.1093/geronj/44.1.B4 · DOI
- Thoman, 1989, Adv. Immunol., 46, 221, 10.1016/S0065-2776(08)60655-0 · DOI · Paper page
- Qin, 2004, Cell. Mol. Immunol., 1, 148
- 10.1016/j.vaccine.2004.07.014 · DOI
- Sen, 2006, Infect. Immun., 74, 2177, 10.1128/IAI.74.4.2177-2186.2006 · DOI
- 10.1073/pnas.95.26.15553 · DOI · Paper page
- Diamant, 1993, Pediatr. Infect. Dis. J., 12, 877, 10.1097/00006454-199310000-00014 · DOI
- Wong, 1996, Int. J. STD AIDS, 7, 490, 10.1258/0956462961918563 · DOI
- 10.1182/blood.V98.10.3016 · DOI · Paper page
- 10.4049/jimmunol.170.9.4717 · DOI
- Mapletoft, 2006, Virology, 353, 316, 10.1016/j.virol.2006.06.001 · DOI
- Linghua, 2008, Vaccine, 26, 224, 10.1016/j.vaccine.2007.10.058 · DOI
- Linghua, 2007, Vet. Immunol. Immunopathol., 115, 216, 10.1016/j.vetimm.2006.10.017 · DOI
- 10.1006/cimm.1996.0009 · DOI · Paper page
- Verthelyi, 2002, J. Immunol., 168, 1659, 10.4049/jimmunol.168.4.1659 · DOI
- Davis, 2000, Vaccine, 18, 1920, 10.1016/S0264-410X(99)00443-0 · DOI
- Jones, 1999, Vaccine, 17, 3065, 10.1016/S0264-410X(99)00145-0 · DOI
- 10.4049/jimmunol.164.3.1617 · DOI · Paper page
- Verthelyi, 2004, AIDS, 18, 1003, 10.1097/00002030-200404300-00007 · DOI
- Klinman, 2004, Vaccine, 22, 2881, 10.1016/j.vaccine.2003.12.020 · DOI
- Steinhagen, 2010, Vaccine
- 10.1007/s10875-004-6244-3 · DOI · Paper page
- 10.1016/S0264-410X(03)00045-8 · DOI · Paper page
- 10.1371/journal.pone.0002940 · DOI
- Traore, 2009, Vaccine, 27, 7299, 10.1016/j.vaccine.2009.08.023 · DOI
- 10.1097/01.aids.0000183514.37513.d2 · DOI
- 10.1086/653112 · DOI
- 10.1172/JCI23373 · DOI · Paper page
- 10.1073/pnas.0703395104 · DOI · Paper page
- 10.1158/1078-0432.CCR-08-0526 · DOI
- 10.1002/ijc.24850 · DOI
- 10.1200/JCO.2010.28.9793 · DOI · Paper page
- Gilkeson, 1993, Clin. Immunol. Immunopathol., 68, 283, 10.1006/clin.1993.1129 · DOI
- 10.1172/JCI117793 · DOI
- Steinberg, 1990, Immunol. Rev., 118, 129, 10.1111/j.1600-065X.1990.tb00815.x · DOI
- Klinman, 1990, J. Clin. Invest., 86, 1249, 10.1172/JCI114831 · DOI
- Linker-Israeli, 1991, J. Immunol., 147, 117, 10.4049/jimmunol.147.1.117 · DOI · Paper page
- Krieg, 1995, J. Clin. Immunol., 15, 284, 10.1007/BF01541318 · DOI
- Yi, 1996, J. Immunol., 157, 4918, 10.4049/jimmunol.157.11.4918 · DOI
- Mor, 1997, Hum. Gene Ther., 8, 293, 10.1089/hum.1997.8.3-293 · DOI
- Katsumi, 1994, Hum. Gene Ther., 5, 1335, 10.1089/hum.1994.5.11-1335 · DOI
- Gilkeson, 1998, J. Immunol., 161, 3890, 10.4049/jimmunol.161.8.3890 · DOI
- Segal, 1997, J. Immunol., 158, 5087, 10.4049/jimmunol.158.11.5087 · DOI
- Segal, 2000, J. Immunol., 164, 5683, 10.4049/jimmunol.164.11.5683 · DOI
- Bachmaier, 1999, Science, 283, 1335, 10.1126/science.283.5406.1335 · DOI · Paper page
- Zeuner, 2003, Arthritis Rheum., 48, 1701, 10.1002/art.11035 · DOI
- 10.1038/nbt0508-484a · DOI
- Le, 1999, J. Rheumatol., 26, 191
- Allen, 1993, Thorax, 48, 580, 10.1136/thx.48.5.580 · DOI
- Opal, 2010, Contrib. Nephrol., 167, 14, 10.1159/000315915 · DOI · Paper page
- Cowdery, 1996, J. Immunol., 156, 4570, 10.4049/jimmunol.156.12.4570 · DOI · Paper page
- Hartmann, 1996, Mol. Med., 2, 429, 10.1007/BF03401902 · DOI
- Klinman, 1999, Infect. Immun., 67, 5658, 10.1128/IAI.67.11.5658-5663.1999 · DOI
- 10.1097/00002371-200411000-00006 · DOI
- 10.1016/j.vaccine.2009.10.087 · DOI
- 10.1016/j.vaccine.2004.01.058 · DOI
- 10.4049/jimmunol.175.5.3084 · DOI
- 10.1016/j.coi.2008.07.007 · DOI
- Ullrich, 2008, Cytokine Growth Factor Rev., 19, 79, 10.1016/j.cytogfr.2007.10.009 · DOI
- 10.1086/533467 · DOI
Cited by
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Recent progress in adjuvant discovery for peptide-based subunit vaccines
Azmi, F., Ahmad Fuaad, A. A. H., Skwarczynski, M., & Toth, I. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27332 · Cited by 239
Sweeten PAMPs: Role of sugar complexed PAMPs in innate immunity and vaccine biology
Mahla, R. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00248 · Cited by 239
Yoshida, S., Nakagami, H., Hayashi, H., Ikeda, Y., Sun, J., Tenma, A., Tomioka, H., Kawano, T., Shimamura, M., Morishita, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16347-w · Cited by 161
Kwissa, M., Nakaya, H. I., Oluoch, H., & Pulendran, B. (2012) · Blood · doi:10.1182/blood-2011-10-388579 · Cited by 132
Metadata
- Authors
- Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 10
- Issue
- 4
- Pages
- 499-511
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2110223801
- Cited by
- 891
- References
- 10
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CpG DNA as a vaccine adjuvant. https://app.cochat.ai/papers/10.1586/erv.10.174
- The paper
- Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011). CpG DNA as a vaccine adjuvant. Expert Review of Vaccines. https://doi.org/10.1586/erv.10.174
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.